66217-20-7

Usage

Uses

Used in Organic Synthesis:
2-BROMO-6-BUTOXYNAPHTHALENE is used as a building block in organic synthesis for facilitating a range of chemical reactions. Its unique structure allows it to be a versatile component in the creation of more complex organic molecules.
Used in Material Development:
In the field of material development, 2-BROMO-6-BUTOXYNAPHTHALENE is studied for its potential to contribute to the creation of new materials, possibly due to its structural properties that can influence the characteristics of the resulting materials.
Used in Pharmaceutical Development:
2-BROMO-6-BUTOXYNAPHTHALENE is also considered in pharmaceutical research, where it may serve as a precursor or intermediate in the synthesis of new drugs, taking advantage of its reactive sites for further chemical modifications.
Used in Environmental Research:
Given its persistence and potential to bioaccumulate, 2-BROMO-6-BUTOXYNAPHTHALENE is a subject of environmental research. Understanding its behavior in ecosystems is crucial for assessing its impact and developing strategies for safe handling and disposal to mitigate its potential as an environmental pollutant.

InChI:InChI=1/C14H15BrO/c1-2-3-8-16-14-7-5-11-9-13(15)6-4-12(11)10-14/h4-7,9-10H,2-3,8H2,1H3

Upstream product

• 109-65-9 1-bromo-butane 
• 15231-91-1 6-bromo-naphthalen-2-ol 

Downstream Products

• 100807-86-1 2-butoxy-6-(4-nitro-phenyl)-naphthalene 

Relevant academic research and scientific papers

Naphthylisopropylamine and N-benzylamphetamine derivatives as monoamine oxidase inhibitors

A series of naphthylisopropylamine and N-benzyl-4-methylthioamphetamine derivatives were evaluated as monoamine oxidase inhibitors. Their potencies were compared with those of a series of amphetamine derivatives, to test if the increase of electron richness of the aromatic ring and overall size of the molecule might improve their potency as enzyme inhibitors. Molecular dockings were performed to gain insight regarding the binding mode of these inhibitors and rationalize their different potencies. In the case of naphthylisopropylamine derivatives, the increased electron-donating capacity and size of the aromatic moiety resulting from replacement of the phenyl ring of amphetamine derivatives by a naphthalene system resulted in more potent compounds. In the other case, extension of the arylisopropylamine molecule by N-benzylation of the amino group led to a decrease in potency as monoamine oxidase inhibitors.

Novel chiral bis-dipolar 6,6'-disubstituted binaphthol derivatives for second-order nonlinear optics: Synthesis and linear and nonlinear optical properties

A number of thermally and optically stable, bis-dipolar chiral molecules based on two geometries of the binaphthol (BN) system with different acceptors/substituents have been synthesized for the first time, and the synthetic routes are reported: optically

Method of inhibiting leukotriene biosynthesis by oral administration of p-aminophenols or derivatives thereof

A method is provided for inhibiting leukotriene biosynthesis and thus treating asthma, psoriasis or inflammation by oral administration of p-aminophenols having the structure STR1 wherein m is 0 to 5; X is CH or N; R1 and R2 may be the same or different and are H, lower alkyl, aryl, hydroxy, hydroxyalkyleneoxy, alkylthio, alkoxy, alkanoyloxy, aryloxy, halo, carboxy, alkoxycarbonyl or amido; R3 is H, lower alkyl, alkanoyl or aroyl; and R4 is H, lower alkyl, benzoyl or alkanoyl, and including acid-addition salts thereof, with the proviso that when R4 is benzoyl, R2 is other than H.

Quinoline compounds and compositions thereof

p-Aminophenols are provided having the structure STR1 wherein m is 0 to 5; X is CH or N; R1 and R2 may be the same or different and are H, lower alkyl, aryl, hydroxy, hydroxyalkyleneoxy, alkylthio, alkoxy, alkanoyloxy, aryloxy, halo, carboxy, alkoxycarbonyl or amido; R3 is H, lower alkyl, alkanoyl or aroyl; and R4 is H, lower alkyl or alkanoyl, and including acid-addition salts thereof, with the proviso that when X is CH, m is 0 and R1 is H, and when R4 is H, R2 is other than alkoxy, H or hydroxy, and when R4 is benzoyl, R2 is other than H. These compounds together with the compounds defined in the above proviso are useful as inhibitors of leukotriene production and as such are useful as antiallergy, anti-inflammatory and anti-psoriatic agents.

Synthese und fluessigkristalline Eigenschaften 2,6-disubstituierter Naphtaline

The syntheses and the mesomorphic properties of a series of novel 2,6-disubstituted naphthalenes are described. 4-benzonitriles 5 and 4-benzonitriles 8 exhibit wide-range nematic mesophases. 6,6'-Di(n-Alkyl)-2,2'-binaphthyls 6 have been isolated as by-products from the reaction mixtures of 5.Some of these novel compounds have polymorphic properties.The esters 13 and 15 of 4-(6-hydroxy-2-naphthyl)benzonitrile show enhanced mesophase stabilities which reach maximum values in the series of α,β-unsaturated esters 15.The 4-(n-pentyl)benzoate 14 of the same (hydroxynaphthyl)benzonitrile has a melting point of 125 deg and a clearing point of > 310 deg.This particular derivative belongs to those liquid-crystalline compounds having the broadest purely nematic-phase range.In addition, (RS)-4-(2-pentyl-6-chromanyl)benzonitrile (20) and three compounds with two and four laterally arranged CN groups at the bicyclooctene, bicyclooctadiene, and phenyl-ring systems 31-33 were synthesized.Only 20 shows mesomorphic properties.